Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Participants With Generalized Anxiety Disorder.
This study has finished and is no longer accepting participants.
In BeijingA Phase 2, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder
This study ended early.
Multiple locations, including PhoenixAn Open Label, Prospective, Non-Comparative Study to Evaluate Flexible Dose of Paliperidone ER and Clinical Response in the Treatment of Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedAn Open-label, Sequential Cohorts, Flexible Dose Study to Evaluate the Tolerability, Safety and Pharmacokinetics of Iloperidone in Elderly Patients With Parkinson's Disease Psychosis (PDP)
This study was withdrawn before enrollment.
In St. PetersburgThis study evaluated the safety of Iloperidone for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveA Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of KYN-5356 as Adjunctive Treatment in Adults With Cognitive Impairment Associated With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Phase 2, Double-Blind, Proof of Concept Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including ScottsdaleA Phase 2 Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate Pharmacodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of TAK-831 in Adult Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
In GaithersburgA Study to Evaluate Switching From Risperidone to Paliperidone ER (Extended Release) in the Treatment of Stable But Symptomatic Schizophrenia Outpatients: Patients Satisfaction and Quality of Life
This study has finished and is no longer accepting participants.
Multiple locations, including Belo HorizonteThis study evaluated the safety of JNJ-31001074 for people with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listedThis study evaluated the safety of JNJ-31001074 for people with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listed
Evaluating the Feasibility of a Primary Care-based Treatment for Restrictive Eating Disorders in Children and Adolescents in the Health System
This study is by invitation only.
In RochesterWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.